DIA RA Community Webinar: China Guest Speaker on 2021 Drug Approval Metrics
DIA RA Community Webinar: Overview of 2021 Drug Approval Metrics and analysis by the Center for Drug Evaluation (CDE) of the National Medical Products Association (NMPA) China Speaker: Kris Wang, Associate Regulatory Affairs Director, Novo Nordisk (China) Pharmaceutical Co., Ltd AND a Core Member of the the DIA Regulatory Affairs Community China DATE: Tuesday 22 March 2022 at 8 pm ET/5 pm PT (Note time change to allow for a live presentation)
https://diaglobal.zoom.us/j/98645732541?pwd=bEV3VUhOdjN5TzJnRWNXc3VydnZ4QT09
Meeting ID: 986 4573 2541
Passcode: 804921
One tap mobile
+13017158592,,98645732541# US (Washington DC)
+13126266799,,98645732541# US (Chicago)
Dial by your location
+1 301 715 8592 US (Washington DC)
+1 312 626 6799 US (Chicago)
+1 646 876 9923 US (New York)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+1 669 900 6833 US (San Jose)
877 853 5257 US Toll-free
855 880 1246 US Toll-free
Meeting ID: 986 4573 2541
--------------------
https://communities.diaglobal.org/post/RorGaN6LHZrRGpC92
https://diaglobal.zoom.us/j/98645732541?pwd=bEV3VUhOdjN5TzJnRWNXc3VydnZ4QT09